Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
Clinical trial NCT06579092 · COMPLETED
Trial details
- NCT number
- NCT06579092
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2025-11-21
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.